AU2002315330A1 - Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid - Google Patents
Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acidInfo
- Publication number
- AU2002315330A1 AU2002315330A1 AU2002315330A AU2002315330A AU2002315330A1 AU 2002315330 A1 AU2002315330 A1 AU 2002315330A1 AU 2002315330 A AU2002315330 A AU 2002315330A AU 2002315330 A AU2002315330 A AU 2002315330A AU 2002315330 A1 AU2002315330 A1 AU 2002315330A1
- Authority
- AU
- Australia
- Prior art keywords
- bronchoconstriction
- aerosolized
- treatment
- hyaluronic acid
- conditions associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 206010006482 Bronchospasm Diseases 0.000 title 1
- 230000007885 bronchoconstriction Effects 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
- 230000000241 respiratory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29836901P | 2001-06-15 | 2001-06-15 | |
| US60/298,369 | 2001-06-15 | ||
| PCT/US2002/019269 WO2002102317A2 (en) | 2001-06-15 | 2002-06-17 | Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002315330A1 true AU2002315330A1 (en) | 2003-01-02 |
Family
ID=23150202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002315330A Abandoned AU2002315330A1 (en) | 2001-06-15 | 2002-06-17 | Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002315330A1 (en) |
| WO (1) | WO2002102317A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2847818B1 (en) * | 2002-11-28 | 2008-04-04 | Agro Ind Rech S Et Dev Ard | PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID |
| IT1401494B1 (en) * | 2010-07-30 | 2013-07-26 | Eupharma Srl | INHALATION FORMULATIONS IN THE FORM OF SOLUTIONS OR DRIED POWDERS, FOR THE REMOVAL OF MUCOSE SECRECTIONS FROM THE RESPIRATORY SYSTEM |
| US9717752B2 (en) | 2012-05-15 | 2017-08-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Uses of antagonists of hyaluronan signaling |
| WO2019200274A1 (en) * | 2018-04-12 | 2019-10-17 | MatRx Therapeutics Corporation | Compositions and methods for treating elastic fiber breakdown |
| IT202100001349A1 (en) * | 2021-01-25 | 2022-07-25 | Sofar Swiss Sa | COMPOSITION IN THE FORM OF DRY POWDER FOR INHALATION COMPRISING A HYALURONIC ACID AND A CHONDROITIN SULPHATE, USE OF THE COMPOSITION AND INHALER DEVICE CONTAINING THE COMPOSITION |
| IT202100021602A1 (en) * | 2021-08-09 | 2023-02-09 | Sofar Spa | Composition in dry powder form for inhalation for use in a method of treatment of inflammation and/or oxidative stress of the respiratory system caused/or by air pollution |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001264817A1 (en) * | 2000-05-23 | 2001-12-17 | Exhale Therapeutics, Inc. | Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans |
-
2002
- 2002-06-17 WO PCT/US2002/019269 patent/WO2002102317A2/en not_active Ceased
- 2002-06-17 AU AU2002315330A patent/AU2002315330A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002102317A3 (en) | 2003-09-18 |
| WO2002102317A2 (en) | 2002-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003249736A1 (en) | Purified polymers for coatings of implantable medical devices | |
| AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
| AU2002332430A1 (en) | Methods of treating neuropilin-mediated diseases | |
| AU2003235248A1 (en) | Hyaluronic acid modification product | |
| AU2002301683A1 (en) | Phosphonic acid derivative treatment of metallic flakes | |
| AU2002307432A1 (en) | Production of alpha-lipoic acid | |
| AU2003234051A1 (en) | Process for the production of acetic acid | |
| GB0119435D0 (en) | Method of treating of demyelinating diseases or conditions | |
| AU2003261657A1 (en) | Promoter for the production of hyaluronic acid containing ginsenoside compound k | |
| AU2002315330A1 (en) | Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid | |
| AU2003294100A1 (en) | Use of hyaluronic acid for respiratory disorders or the upper airways | |
| AU2002249947A1 (en) | Inhibition of protein-phosphatases for the treatment of heart failure | |
| AU2002251254A1 (en) | Treatment of neuropathologies associated with expression of tnf-alpha | |
| AUPR381601A0 (en) | Method of treating respiratory conditions | |
| AU2003242832A1 (en) | Process for the production of acetic acid | |
| AU2002251202A1 (en) | Intimins for the prevention or treatment of infections: i | |
| AU2002347652A1 (en) | Process for the preparation of an enantiomerically enriched a-amino acid | |
| AU2002364335A1 (en) | Use of lactic acid bacteria for producing alpha-ketoglutarate | |
| AU2002351560A1 (en) | Treatment of congestive heart failure | |
| AU2003230053A1 (en) | Process for the manufacture of 4-fluoro-anthranilic acid | |
| AU2002308350A1 (en) | Use of hyaluronic acid uronides for the treatment of inflammatory processes | |
| AU2003271712A1 (en) | Treatment of amm | |
| AUPS327102A0 (en) | Method of treatment or prophylaxis of gastrointestinal diseases | |
| AU2002252987A1 (en) | Method for the continuous production of medicaments for inhalation | |
| AU2003272553A1 (en) | Treatment of schizophrenia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |